Elicit maps 138 AI vendors across 58 pharma functions, reveals gaps
jungofthewon · x · 2026-11-06
Elicit's AI-for-Pharma market map places 138 companies selling AI into pharma on a big-pharma org chart covering 58 functions. Key findings: VC money heavily favors research ($5.5B) over commercial ($1B) and manufacturing (single-digit millions); antibody design is crowded (7 vendors) while phage, nucleic acid, and cell & gene therapy have one each and vaccines/radiopharma none; frontier labs (Anthropic, OpenAI, Google) compete in target ID but are absent from pharmacovigilance, biometrics, regulatory strategy, quality, and manufacturing; 73 of 138 AI-natives sit on a single function.
Related event: AI Pharma Landscape Maps 138 Companies Across 58 Functions(3 posts)→
More from AGI Musings
- Decentralized AI artist Botto opens Taipei exhibition with live collaboration from creator Mario Klingemann — hudsonsims · 2026-11-06
- cyb3rops: AI Audits Reveal 40 Years of Software Was Security by Obscurity — cyb3rops · 2026-11-06
- Rob Leclerc: the AI-bubble narrative is winning, but agents will drive 10x growth — robleclerc · 2026-11-06
- Perplexity CEO: everyone will have a team of agents setting direction for them — AravSrinivas · 2026-11-06
- Yunta Tsai: In the compute era, information will be priced in compute — yunta_tsai · 2026-11-06
- 'AI Is Like Electricity' Undersells It: AI Can Autonomously Move Atoms — danfaggella · 2026-11-06